APLT

APLT

USD

Applied Therapeutics Inc. Common Stock

$0.365+0.000 (0.000%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.365

Máximo

$0.385

Mínimo

$0.360

Volumen

1.09M

Fundamentos de la Empresa

Capitalización de Mercado

51.7M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.18M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.295Actual $0.365Máximo $10.624

Noticias Relacionadas

GlobeNewswire

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in

Ver más
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Analyst Upgrades

RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics with a Sector Perform and maintains $1.5 price target.

Ver más
RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.